Global new-born screening equipment sales were valued at around US$ 485 Mn at the end of 2021. The market is projected to register a 7.8% CAGR and top a valuation of US$ 1100 Mn by 2032.
Rapid technological advancement, rise in demand for new-born diagnosis and growing need for infant’s safety are expected to uplift the new-born screening equipment market growth.
Neonatal screening, often known as new-born screening, is a process to identify certain developmental, harmful, genetic, or metabolic problems that, if left untreated, may cause mental retardation or even death.
New-born screening is a public health initiative carried out by a number of hospitals where new-borns are checked and found with rare but critical medical disorders such as hormonal, genetic or metabolic conditions that may impede their development. In certain circumstances, the symptoms or signs are absent but the disorder can still be recognized with the help of screening. New-born screening is crucial since it can identify numerous diseases or birth defects that can be treated effectively and save a new-born's life.
| Attributes | Details |
|---|---|
| New-Born Screening Equipment Market Value in 2021 | US$ 485 Million |
| New-Born Screening Equipment Market Value in 2032 | US$ 1100 Million |
| New-Born Screening Equipment Market CAGR (2022 to 2032) | 7.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market for new-born screening equipment is fuelled by the prevalence of neonatal diseases has increased, leading to a dramatic increase in mortality rates. Furthermore, securing funding from government sectors for new-born screening, improving new-born screening programs, and advancements in technologies in new-born screening are all contributing factors to the market's expansion.
Additionally, rising congenital disease incidence in infants is also anticipated to raise demand for new-born screening equipment. Nowadays, the increasing infant population is one of the major drivers to boost the market expansion of new-born screening equipment. Furthermore, the development of oximeters and mass spectrometers with increased performance is anticipated to boost market expansion.
Due to expanding testing requirements throughout all 50 states and the rising prevalence of congenital diseases, North America dominates the market for new-born screening equipment. To increase awareness, state health agencies in the U.S. have published free information and developed websites, which make it easier for parents to deal with congenital diseases. This is the most prominent reason behind the market expansion in this region.
The new-born screening equipment market in Europe is expected to expand at a rapid pace. Advancements in the healthcare industry and the presence of well-established key players boost the market expansion in this region. Due to awareness campaigns, new-born diagnostic procedure quality assurance and rising birth rate, the South and East Asia markets are displaying a lucrative growth opportunity.
Principal Consultant
Some of the market players operating in the new-born screening equipment market are Gilent Technologies, Bio-Rad Laboratories, Covidien PLC, GE Life Sciences, Masimo Corporation, Natus Medical Inc., PerkinElmer Inc., Trivitron Healthcare, GE Healthcare, and ZenTech S.A.
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 7.8% 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2012 to 2021 |
| Forecast Period | 2022 to 2032 |
| Qualitative Units | Revenue in USD Billion, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segment Covered | Product, Test Type, Technology, End User, Region |
| Region Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East & Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, China, Japan, South Korea, Malaysia, Singapore, Australia, New Zealand, GCC, South Africa, Israel |
| Key Players | Gilent Technologies; Bio-Rad Laboratories; Covidien PLC; GE Life Sciences; Masimo Corporation; Natus Medical Inc.; PerkinElmer Inc.; Trivitron Healthcare; GE Healthcare; ZenTech S.A |
| Customization | Available Upon Request |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global new-born screening equipment market is anticipated to register a CAGR of 7.8% during the forecast period.
The top players in the global new-born screening equipment market are Gilent Technologies, Bio-Rad Laboratories, Covidien PLC, GE Life Sciences, Masimo Corporation, Natus Medical Inc., PerkinElmer Inc., Trivitron Healthcare, GE Healthcare, and ZenTech S.A.
Explore Healthcare Insights
View Reports
New-Born Screening Equipment Market
